Tracking iron rims around MS lesions over time
Official title: Longitudinal Assessment of Iron Rims in White Matter MS Lesions as a Marker of Disability
Run by Nottingham University Hospitals NHS Trust · NCT05123443 · Data updated 2026-11-12
This project will test whether genetic differences predict which people with MS develop iron rims around white matter lesions.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 16 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Nottingham University Hospitals NHS Trust Academic / other |
| Locations | 1 site (Nottingham) |
| Status | Recruiting |
| Started | September 3, 2022 |
| Main results expected | July 31, 2026 |
| Study ends | July 31, 2027 |
| Registry record updated | March 12, 2026 |
| Trial ID | NCT05123443 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults (≥16) with a confirmed MS diagnosis who have an existing susceptibility-weighted brain MRI from 2008–2012 and are willing to provide a blood sample and attend a 7T MRI visit.
✕Probably not a fit
Patients without prior susceptibility-weighted MRI scans, those unable to undergo 7T MRI, or those unwilling or unable to consent are unlikely to benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study follows a cohort of MS patients who had susceptibility-weighted brain MRI scans between 2008 and 2012 and combines those historic images with new ultra-high-field (7T) and 3T MRI to track iron rim lesions over time. Participants provide blood samples for genotyping to look for genetic variants that might influence the formation or persistence of iron rim lesions. The team will correlate lesion evolution with clinical disability and disease progression measures to see whether iron rims predict a more severe course. Johns Hopkins collaborators and Nottingham University Hospitals will use standardized imaging reads and longitudinal clinical data to analyze lesion dynamics and genetic associations.
Why it matters
Potential benefit: If successful, this work could help identify patients at higher risk of disease progression earlier, enabling more personalized monitoring and treatment decisions.
How similar studies have gone: Previous cross-sectional studies have linked iron rim lesions to progressive MS, but large longitudinal cohorts and genetic linkage studies are limited, making this approach partly supported but still novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Men and women aged above 16 years * Clinical diagnosis of MS as per revised McDonald Criteria 2017 * Existing susceptibility-weighted brain MRI scan * Able to provide blood samples Exclusion Criteria: * Unwilling or unable to comply with the requirements of this protocol including the presence of any condition (physical, mental or social) that, in the opinion of the PI, is likely to affect the participants ability to comply with the study protocol. * Unable to provide informed consent.
Where it's running
-
Nottingham University NHS Trust
Nottingham, United Kingdom Recruiting
Study contacts
- Study coordinator: Ryan Mamun
- Email: Ryan.Mamun1@nhs.net
- Phone: +447490225520
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Treadmill-based virtual reality walking training for MS patients
This study tests whether a treadmill with virtual reality and smart socks can help people with multiple sclerosis walk better and feel safer in daily life.
-
Virtual Reality and Mental Practice to Improve Balance and Walking in Relapsing MS
This study tests whether virtual reality training or mental practice can improve balance and walking in people with relapsing–remitting multiple sclerosis.
-
REAL-MS: A Look at Autologous Stem Cell Transplant vs High-Efficacy MS Therapies in Real-World Care
This study tests how AHSCT compares to high-efficacy MS medicines in adults treated in routine clinical care.
-
Tolebrutinib in real-world MS care for patients treated by clinicians
This real-world study sees how tolebrutinib is used for multiple sclerosis patients and what outcomes look like in everyday practice.
-
Pilates via live video vs. prerecorded videos for people with multiple sclerosis
This study tests whether live, coach-led Pilates sessions through video calls are more beneficial than prerecorded Pilates videos for adults with MS.
-
Cooling During Inpatient Rehab for People with MS
This trial tests whether wearing a cooling vest during intensive training can reduce fatigue and improve walking, strength, balance, and cognition in people with multiple sclerosis during a 3-week inpatient rehab stay.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.